Why is Ishita Drugs falling/rising?

As of 28-Oct, Ishita Drugs & Industries Ltd is experiencing a decline in its stock price, currently at 72.10, which represents a decrease of 1.42 or 1.93%. The stock has underperformed its sector by 1.67% today and has been on a consecutive downward trend for the last two days, accumulating a total decline of 3.03%. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Over the past week, the stock has fallen by 2.91%, and its year-to-date performance shows a significant decline of 22.00%, contrasting sharply with the Sensex, which has gained 8.30% during the same period. Unfortunately, there is no information available regarding positive or negative factors that could further clarify the stock's recent movement.
Broader Market Context: In comparison to the benchmark, Ishita Drugs has significantly underperformed, with a 1-month return of -11.64% against the Sensex's gain of 5.22%. This stark contrast highlights the stock's struggles in the current market environment, where it has not only lagged behind the benchmark but also shown a consistent downward trajectory over various time frames. The rising investor participation, indicated by a 57.62% increase in delivery volume, suggests some interest in the stock, but it has not been enough to counteract the overall negative performance.